Literature DB >> 1464496

Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI.

B A Berkowitz1, P S Tofts, H A Sen, N Ando, E de Juan.   

Abstract

Dynamic T1-weighted magnetic resonance imaging (MRI) after the injection of Gd-DTPA is a promising method for investigating breakdown of the blood-retinal barrier (BRB). Previously, the authors demonstrated that in a T1-weighted image, the initial rate of change in the vitreous water MRI signal as gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA) enters the vitreous space strongly correlated with the extent of BRB breakdown. Here, a practical approach to measuring a more relevant physiologic parameter is presented: the permeability surface area product (PS). The theory is a development of earlier work used in investigating the breakdown of the blood-brain barrier. The accuracy and precision of this approach was investigated in rabbits pretreated with sodium iodate (30 mg/kg intravenously). The MRI-derived PS normalized to the area of leaky retina (5.65 +/- 0.25 x 10(-4) cm/min, mean +/- standard error of the mean; n = 6) was compared to a similarly normalized PS calculated using a classical physiologic method (4.12 +/- 0.73 x 10(-4) cm/min; n = 6). Good agreement between the two methods was found (P = 0.09). This result demonstrates that the MRI-derived PS is an accurate and precise measure of BRB breakdown under these conditions. The mathematical model of Gd-DTPA distribution in vivo also is validated. Based on these results, several potential sources of error are discussed, including the effect of back-flow of Gd-DTPA from the vitreous space to the plasma, the underlying vascular patency, and MRI slice selection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1464496

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  In vivo localized 1H spectroscopy of the rat eye at 7 T: preliminary studies.

Authors:  S Crozier; D M Doddrell
Journal:  MAGMA       Date:  1995 Sep-Dec       Impact factor: 2.310

2.  Cell swelling contributes to thickening of low-dose N-methyl-D-aspartate-induced retinal edema.

Authors:  Junjie Chen; Chia-Wen Chiang; Huiying Zhang; Sheng-Kwei Song
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-09       Impact factor: 4.799

3.  Assessment of subconjunctival delivery with model ionic permeants and magnetic resonance imaging.

Authors:  S Kevin Li; Sarah A Molokhia; Eun-Kee Jeong
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

4.  The steroid effect on the blood-ocular barrier change induced by triolein emulsion as seen on contrast-enhanced MR images.

Authors:  Jong Yuk Lee; Choong Ki Eun; Yong Woo Kim; Hak Jin Kim; Yeon Joo Jung; Seung Youn Jae; Byung Mann Cho; Seon Hee Choi
Journal:  Korean J Radiol       Date:  2008 May-Jun       Impact factor: 3.500

5.  Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury.

Authors:  Bruce A Berkowitz; Robin Roberts; Hongmei Luan; David Bissig; Bang V Bui; Marius Gradianu; David J Calkins; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

Review 6.  Evidence for a critical role of panretinal pathophysiology in experimental ROP.

Authors:  Bruce A Berkowitz; Robin Roberts
Journal:  Doc Ophthalmol       Date:  2009-06-09       Impact factor: 2.379

Review 7.  MRI of rod cell compartment-specific function in disease and treatment in vivo.

Authors:  Bruce A Berkowitz; David Bissig; Robin Roberts
Journal:  Prog Retin Eye Res       Date:  2015-09-04       Impact factor: 21.198

Review 8.  MRI in ocular drug delivery.

Authors:  S Kevin Li; Martin J Lizak; Eun-Kee Jeong
Journal:  NMR Biomed       Date:  2008-11       Impact factor: 4.044

9.  Toward clinical application of manganese-enhanced MRI of retinal function.

Authors:  Paul S Tofts; Andre Porchia; Ying Jin; Robin Roberts; Bruce A Berkowitz
Journal:  Brain Res Bull       Date:  2009-06-11       Impact factor: 4.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.